Artificial Intelligence in Medicine: A New Perspective on Diagnostics
Artificial intelligence (AI) is a field of science that enables computer programs to simulate human thinking and perform various tasks requiring intelligence [1, 2, 8]. In recent years, AI has achieved significant success in various interdisciplinary fields, including healthcare. Its applications span precision prevention, diagnosis, and disease management, promising to revolutionize medical practice [2]. Ophthalmology is one of those medical fields where artificial intelligence methods are demonstrating particularly rapid progress, offering new approaches to preventing vision loss in various eye diseases [1].
Ophthalmology at the Forefront of AI Technologies: Why Is It Important?
Ophthalmology is at the forefront of integrating AI into medicine, driven by several key factors. The diagnosis of many eye diseases relies heavily on imaging [2, 5]. Digital methods such as optical coherence tomography (OCT) and visual field testing generate vast amounts of data that are ideally suited for AI analysis [1, 4]. These technologies allow AI to quickly and efficiently process images, identifying subtle changes that may be imperceptible to the human eye [7].
Given the aging population and the growing need for broader screening coverage, AI systems can become a key tool for optimizing screening, staging, and treatment planning processes for vision-threatening conditions. This helps relieve experts of routine tasks, expand population coverage, and ensure optimal care for every patient [7]. Annual examinations are crucial for the early detection of diseases such as glaucoma and diabetic retinopathy, and AI can significantly enhance their effectiveness [1].
Key Eye Diseases Diagnosed Using AI
Artificial intelligence is already actively used in the diagnosis and management of many common eye diseases leading to vision impairment and blindness:
- Diabetic Retinopathy (DR): This is one of the most frequent complications of diabetes, leading to vision loss. Deep learning-based AI models are successfully used for DR screening and prognosis, helping to detect the disease in its early stages [2, 8].
- Glaucoma: A progressive optic neuropathy characterized by the loss of retinal ganglion cell axons and visual field defects. Glaucoma often remains poorly understood, and its early and accurate diagnosis, as well as the prediction of its progression, present significant difficulties [3]. AI can be a game-changer, paving the way for the first cost-effective glaucoma screening campaigns and demonstrating excellent diagnostic performance in fundus image analysis [3, 6].
- Age-Related Macular Degeneration (AMD): A common cause of central vision loss in older adults. AI applications are actively being developed for the diagnosis and monitoring of AMD [1, 2, 8].
- Cataract: AI models are also applied for cataract screening and prognosis, helping to determine the need for surgical intervention [2].
- Macular Holes (MH): Artificial intelligence is used to evaluate and support the treatment of macular holes [1].
- Multiple Sclerosis (MS): Although MS is an autoimmune disease of the central nervous system, it often affects the optic nerve. AI-based analysis of MRI and OCT data is becoming increasingly important for early diagnosis, monitoring, and treatment efficacy assessment in MS patients, especially at a young age [4].
Principles of AI Operation: From Machine Learning to Deep Neural Networks
The application of AI in ophthalmology is based on machine learning (ML) and, in particular, deep learning (DL) methods [1, 6]. Machine learning allows computer systems to learn from data without explicit programming. Deep learning, a subset of ML, uses multi-layered computational models that simulate the neural networks of the human brain. These models are capable of learning and recognizing complex patterns in data at various levels of abstraction [2, 4, 6, 7].
The success of AI in medicine is largely due to the development of deep learning algorithms that can analyze various modalities of retinal data, including fundus images, visual field test results, OCT data, and even MRI [4, 6]. These algorithms are capable of detecting minute changes indicative of the onset or progression of a disease, making them an invaluable tool for physicians [2].
Advantages, Challenges, and Prospects of AI in Ophthalmology
The application of AI in ophthalmology offers numerous advantages. It significantly improves early and accurate diagnosis, especially for diseases that are difficult to detect in their initial stages, such as glaucoma [3, 7]. AI facilitates the creation of cost-effective screening campaigns, making high-quality diagnostics more accessible to broad populations, including in developing countries [3, 7]. It also reduces the burden on specialists, allowing them to focus on more complex cases and treatment strategies [7].
However, the implementation of AI also comes with certain challenges. Large volumes of high-quality and diverse data are required to train and validate AI models [6]. There are technical and clinical difficulties in integrating AI into routine practice, as well as heterogeneity in imaging methods and AI approaches [3, 5]. For now, the widespread adoption of AI in clinical practice is limited by accessibility and these complexities [5]. It is important that ophthalmologists understand the principles of AI and perceive it as a "companion" in their practice rather than a replacement [3, 5].
Despite these challenges, the future of AI in ophthalmology looks promising. The development of more advanced models for prognosis, progression assessment, and personalized treatment will continue [6]. AI has the potential to revolutionize screening, staging, and treatment planning for vision-threatening conditions, making medical care more effective, accurate, and accessible [7].
Sources
- Romanian journal of ophthalmology, 2023. Artificial intelligence in ophthalmology.
- Frontiers in public health, 2022. A review of artificial intelligence in diabetic retinopathy and other eye diseases.
- Progress in brain research, 2020. Artificial intelligence and deep learning in glaucoma: Current state and future prospects.
- Caspian journal of internal medicine, 2026. Deep learning in image analysis for multiple sclerosis: Diagnosis and monitoring.
- Seminars in ophthalmology, 2023. Artificial intelligence in ophthalmology - current state and future directions.
- Biomedical engineering online, 2023. Artificial intelligence in glaucoma: Opportunities, challenges, and future directions.
- Survey of ophthalmology, 2022. Artificial intelligence: The unstoppable revolution in ophthalmology.
- Sao Paulo medical journal = Revista paulista de medicina, 2022. Use of artificial intelligence in ophthalmology: A scoping review.
The information provided in the article is for reference purposes only and cannot replace professional medical advice. Always consult a specialist before making decisions regarding your health.